Organ transplants from animals to humans: how it works

The EGINESIS Biotechnology Company recently announced the transplantation of a pig college in a second human patient. The transplants of organs from animals to humans, or Xenotransplant, have been made by applying in the liberation of genes and cloning.

With insufficient human kidneys to meet the demand for transplants, training and other companies aim to help bridge the gap with the help of CRISB-CAS9The technology of the genetics that won 2020 Nobel Prize in Chemistry.

By editing a pig’s genome to remove a targeted sequence of DNA PIG and insert a specific sequence of human DNA, egenesis says it can reduce the risk of organs and infections across species.

“Some people have the wrong belief that we are modifying an adult animal. We do not. We liberate cells, and then we can produce animals from cells,” says Mike Cortis, President and CEO of Egenesis.

The donors are raised in a very controlled environment to reduce the risk of any pathogens that make their way to the facility.

Cortis tells me that Egenesis plans to several additional transplants this year, with the aim of its peak in the experience of about 50 patients, after which the company hopes to obtain sufficient data to make this type of procedure available on a wider scale.

As for the recipient of Xenotransplant Tim Andrews, he got his new college for about two months, and the latest word from egenesis is that it works well.

For more coverage of Xenotrans, check the video in this article.